Sweeteners in E-Cigarettes: A Minireview of Flavoring and Biological Action
Abstract
1. Introduction
2. Materials and Methods
3. E-Cigarette Sweetening Overview
3.1. Natural Sweeteners
- -
- When heated;
- -
- When inhaled vs. taken orally;
- -
- In the presence of other substances.
3.2. Artificial Sweeteners
3.2.1. Sucralose in E-Cigarettes
3.2.2. Other Sweeteners in E-Cigarettes
4. Discussion
5. Future Perspectives of the E-Cigarette Sweetening Investigation
- -
- The comparison of the biological action of taken and inhaled sweeteners due to the metabolic differences;
- -
- The metabolic profile of the sweeteners in the presence of each other and their influence on the biological activity of standard cigarette and cigarette smoke components, including N. tabaccum alkaloids, and their decomposition and combustion products, including polycyclic arenes and hetarenes [85,86]. This interaction may be synergetic, summary, or antagonic, and it is certainly concentration dependent.
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| IC | Ionic Chromatography |
| GC–MS | Gas Chromatography coupled with Mass Spectroscopy |
| ROS | Reactive Oxygen Species |
| HAP | Human Abuse Potential |
| C CNS | Central Nervous System |
| WPT | Waterpipe Tobacco Smoking |
| TTS | Traditional Tobacco Smoking |
Appendix A. E-Cigarette Chemical Composition
Appendix A.1. Brief Overview of Electronic Cigarettes
Appendix A.2. Main Substances of the E-Liquids
Appendix A.2.1. Nicotine and Its Analogues

| Compound | CAS Number | Typical Concentration | Mechanism of Action/Biological Effects | Approx. LD50 (Oral, Rat) | Notes |
|---|---|---|---|---|---|
| Nicotine | 54-11-5 | Cigarettes: ~1 mg/cig; E-liquids: 0–60 mg/mL | Tertiary amine; binds nicotinic acetylcholine receptors; stimulates parasympathetic NS; increases HR, secretion, peristalsis; highly addictive; carcinogenic, mutagenic, teratogenic | 50 mg/kg | Nicotine salts increase receptor saturation and systemic absorption; main addictive component |
| Nornicotine | 65-99-0 | Cigarettes: 0.1–0.2 mg/cig; E-liquids: trace–5 mg/mL | Secondary amine; stronger receptor activity than nicotine; excitatory; additive toxicity | Not well-established | Demethylated nicotine; more potent CNS effects |
| Nicotinic acid (Niacin, Vitamin B3) | 59-67-6 | Cigarettes: trace; E-liquids: trace | Metabolic cofactor for NAD/NADP; minimal receptor activity; formed from oxidation of nicotine/nornicotine | 900 mg/kg | Toxic intermediates formed during metabolism from tobacco alkaloids |
| Anabasine | 494-52-0 | Cigarettes: 0.2–0.5 mg/cig; E-liquids: trace | Nicotine isomer; forms anabasinium salts; mimics nicotine activity; addictive | 11 mg/kg | Potentiates nicotine toxicity; present in trace amounts |
| Cotinine | 486-12-4 | Smokers’ blood: 250–300 ng/mL; E-liquids: <1–10 mg/mL | Nicotine metabolite; weaker CNS stimulation; biomarker of tobacco exposure; mild antidepressant effect | >400 mg/kg | Retention prolonged by menthol; marker of passive smoking |
| Myosmin | 512-12-1 | E-liquids: variable, up to 1–5 mg/mL | Stimulates dopamine and adrenaline release; activates parasympathetic NS; metabolizes to highly toxic intermediates | Not well-established | Increases toxicity when enriched in e-liquids |
| Norharman (β-carboline) | 1656-85-1 | N. rustica: 0.2–0.5 mg/g dry leaves; trace in e-liquids | MAO inhibitor; neuroactive; may potentiate nicotine effects; mutagenic and carcinogenic potential | 100 mg/kg | Found mainly in N. rustica; contributes to addiction and CNS effects |
| Harman (β-carboline) | 123-32-0 | N. rustica: 0.5–1 mg/g dry leaves; trace in e-liquids | MAO inhibitor; neuroactive; can potentiate nicotine; mutagenic, teratogenic, and carcinogenic | 120 mg/kg | Structurally similar to norharman; synergizes with nicotine for addictive potential |
Appendix A.2.2. E-Liquid Fillers

| Compound | CAS Number | Typical Concentration in E-Liquids | Biological/Toxic Effects | Thermal Decomposition/Toxic Products | Notes |
|---|---|---|---|---|---|
| Pyridine | 110-86-1 | Trace (≤0.1%) | Irritates mucous membranes; inhalation: mild euphoria, suffocation, vomiting; high exposure: hypotension, bradycardia, loss of consciousness; interferes with vitamin B1 metabolism | On heating: forms nitrogen oxides, carbon monoxide, and pyridyl radicals; highly toxic | Used to dissolve nicotine and analogues; extreme caution required |
| 1,2-Propanediol (Propylene Glycol) | 57-55-6 | 30–70% of liquid | Generally safe as food additive (E1520); excessive inhalation: throat irritation, cough, minor CNS effects | Decomposes at high temperatures: acrolein, formaldehyde | Main solvent; contributes to vapor formation; relatively safe at standard e-cigarette temperatures |
| 1,3-Propanediol (Trimethylene Glycol) | 504-63-2 | 5–15% | Low toxicity; mild respiratory irritation possible | Thermal decomposition: acrolein, formaldehyde | Used as a thickener and vapor carrier |
| Ethylene Glycol | 107-21-1 | Trace–up to 5% | Highly toxic; metabolized to glycolaldehyde, glycolic acid, oxalic acid; causes nausea, vomiting, CNS depression, renal failure | Decomposes to formaldehyde, acetaldehyde, acrolein | Dangerous if present in high concentration; should be minimized |
| Glycerin (Glycerol) | 56-81-5 | 10–60% | Generally safe; can cause cough or throat irritation | Thermal decomposition: acrolein, acetaldehyde | Major solvent; contributes to visible vapor; safe at moderate temperatures |
| Eucalyptol (1,8-Cineole) | 470-82-6 | Trace—1% | Mild antibacterial; excessive inhalation: CNS effects, nausea, hepatotoxicity | Decomposition: formaldehyde, CO, reactive terpenoids | Flavoring; overuse can increase toxicity |
| Menthol | 89-78-1 | 0.1–2% | Cooling effect; reduces irritation; can induce mild CNS depression at high doses | Decomposition: menthone, reactive aldehydes, CO | Common in mint-flavored e-liquids; can be used as ethers/esters |
| Menthone | 14073-97-3 | Trace | Oxidized form of menthol; similar effects | Decomposition: reactive aldehydes, CO | Flavoring and aroma compound |
| Safrole | 94-59-7 | Trace | Mutagenic, carcinogenic; hepatotoxic | On heating: forms allylbenzene radicals, CO, formaldehyde | Natural aromatic ether; toxic even in small quantities |
| Benzaldehyde | 100-52-7 | Trace—0.5% | Fruity aroma; mutagenic, carcinogenic; irritates respiratory tract | On heating: benzoic acid, CO, benzene derivatives | Flavoring; risk increases with temperature |
| Cinnamic Aldehyde | 104-55-2 | Trace—0.5% | Cinnamon/clove aroma; irritates lung epithelium; can cause bronchiolitis obliterans | Decomposes to cinnamic acid, CO, aldehyde radicals | Strong flavoring; toxic at high concentrations or prolonged inhalation |
Appendix A.2.3. Adverse e-Cigarette Components

| Compound | CAS Number | Typical Concentration | Biological/Toxic Effects | Thermal Decomposition/Toxic Products | Notes |
|---|---|---|---|---|---|
| N-Nitrosodimethylamine (NDMA) | 62–75-9 | Trace–μg/mL | Potent carcinogen; mutagenic; hepatotoxic; may cause internal bleeding, memory loss, coma | Decomposes to NOx, formaldehyde, and methyl radicals | Can form from nitrites and secondary amines; also a by-product of tobacco nitrosation |
| N-Nitrosonornicotine (NNN) | 16,517-33-6 | μg/cigarette; trace in e-liquids | Carcinogenic, mutagenic; liver toxicity; affects fetal health | Thermally stable but can form reactive nitrosyl species | Specific tobacco nitrosamine derived from nornicotine |
| N-Nitrosoanabasine (NAB) | 16,517-34-7 | μg/cigarette; trace in e-liquids | Carcinogenic; liver toxicity; mutagenic; neurotoxic | Can generate reactive nitrogen species when heated | Specific tobacco nitrosamine derived from anabasine |
| Formaldehyde (Methanal) | 50-00-0 | 1–100 μg/puff | Highly toxic; irritant; carcinogenic; mucosal burns; nephrotoxic; respiratory failure | Further oxidizes to formic acid, CO, free radicals | Formed from oxidation of methanol, solvents, or glycerol/propylene glycol at high temperatures |
| Acetaldehyde (Ethanal) | 75-07-0 | 1–50 μg/puff | Moderately toxic; irritant; carcinogenic (Group I); CNS effects; contributes to passive smoking irritation | Oxidizes to acetic acid; forms reactive aldehyde radicals | Produced from ethanol metabolism and tobacco combustion |
| Acrolein (Propenal) | 107-02-8 | 0.5–20 μg/puff | Strong irritant; mutagenic; cytotoxic; used as tear gas; damages respiratory tract | Can polymerize or oxidize to acrylic acid, free radicals | Highly reactive α,β-unsaturated aldehyde formed during thermal decomposition of glycerol or polyols |
| Polynuclear Aromatic Hydrocarbons (PAHs) | Various (see below) | Trace–μg/puff | Carcinogenic; mutagenic; lipophilic; accumulates in tissues | Can oxidize to epoxides, quinones, ROS | Examples: Naphthalene (91-20-3), Anthracene (120-12-7), Phenanthrene (85-01-8), Pyrene (129-00-0), Benzopyrene (50-32-8) |
| Quinoline | 91-22-5 | Trace | Mutagenic, carcinogenic; neurotoxic | Forms reactive nitrogen species upon heating | Pyridine derivative with aromatic ring system; highly active electrophile |
| Acridine | 107-18-6 | Trace | Mutagenic; carcinogenic; DNA intercalator | Forms epoxides, radicals on heating | Pyridine derivative with planar aromatic structure |
| Phenanthridine | 86-42-4 | Trace | Mutagenic; carcinogenic; DNA intercalator | Forms reactive species | Pyridine derivative, highly reactive toward DNA |
| Sulfur(IV) dioxide (SO2) | 7446-09-5 | μg–mg/puff | Irritant of eyes, throat, respiratory tract; causes cough, hoarseness, pulmonary edema | Oxidation/reduction with other smoke components produces sulfites and radicals | Produced from combustion of sulfur-containing compounds (thiols, thiophenes) |
| Fe2+, Zn2+, Mn2+, Cd2+, Ni2+, Cr3+ | Various | Trace–μg/mL | Heavy metal toxicity: nephrotoxic, hepatotoxic, carcinogenic, neurotoxic | Can catalyze oxidative reactions forming ROS | Present from raw materials and manufacturing; often higher in e-cigarettes than conventional cigarettes |
Appendix B. The General Safety Data for Sweeteners Used in E-Cigarettes
| Erythritol | 149-32-6 | 0.1–5% | Low-calorie sugar alcohol; mostly excreted unchanged; generally safe; may cause mild GI upset in excess | Can decompose at high temperatures to formaldehyde, acrolein | Polyol; contributes to sweetness and viscosity |
| Sorbitol | 50-70-4 | 0.1–5% | Sugar alcohol; low-calorie; excessive intake can cause laxative effects | Thermal decomposition: formaldehyde, acrolein, organic acids | Often used to mimic sugar sweetness and as a humectant |
| Xylitol | 87-99-0 | 0.1–5% | Sugar alcohol; anti-cariogenic; mild laxative in excess | Heating: formaldehyde, furfural, acetaldehyde | Common sugar substitute; safe in moderate doses in food but less safe if inhaled |
| Mannitol | 69-65-8 | 0.1–5% | Sugar alcohol; diuretic at high doses; generally low toxicity | Thermal decomposition: formaldehyde, acrolein | Often used for sweetness and viscosity |
| Neohesperidin dihydrochalcone (Neohesperetine) | 20702-77-6 | Trace–0.1% | Non-caloric; sweetener; generally safe; may induce mild GI effects | Heating: phenolic decomposition products, aromatic aldehydes | Natural flavonoid derivative |
| Perillartine | 3248-54-6 | Trace–0.1% | Non-caloric sweetener; safe at low doses; bitter taste at high concentrations | Thermal decomposition: aromatic ketones, reactive aldehydes (at temperatures close to 200 °C) | Sweetener mostly used in Japan; thermally stable; very high sweetness potency |
| Ethyl maltol | 4940-11-8 | Trace–0.5% | Flavor enhancer; low toxicity; possible mild irritation | Thermal decomposition: furans, formaldehyde, acetaldehyde | Commonly used to enhance sweetness perception |
| Mogroside V | 126530-29-9 | Trace–0.5% | Natural sweetener from Siraitia grosvenorii; very low toxicity; non-caloric | Thermal decomposition at temperatures over 1600 C: glycoside hydrolysis products | High-intensity natural sweetener. Can be used in e-liquids due to relative thermal stability |
| Glucose | 50-99-7 | 0.1–5% | Common sugar; high intake can raise blood sugar | Thermal decomposition: caramelization products, HMF (5-hydroxymethylfurfural), CO | Simple sugar; may caramelize at high temperature |
| Sucrose (Sugar) | 57-50-1 | 0.1–5% | Common sugar; excessive intake affects glycemia | Thermal decomposition: caramelization, HMF, CO, aldehydes | Standard sugar; prone to thermal decomposition |
| Fructose | 57-48-7 | 0.1–5% | Simple sugar; high intake can cause GI upset | Thermal decomposition: HMF, aldehydes, CO | High sweetness; forms toxic aldehydes at high temperatures |
| Acesulfame K | 55589-62-3 | Trace–0.5% | Non-caloric sweetener; generally safe; slight bitter aftertaste | Thermal decomposition: acetoacetic derivatives, formaldehyde | Stable under moderate heat; used in combination with other sweeteners |
| Aspartame | 22839-47-0 | Trace–0.5% | Low-calorie sweetener; metabolized to phenylalanine; unsafe for phenylketonuria | Decomposes at high temperature to diketopiperazine, methanol, phenylalanine | Heat-sensitive; commonly used in cold e-liquids. Yields toxic metabolites when inhaled. Metabolizes to methanol |
| Saccharin | 81-07-2 | Trace–0.5% | Non-caloric; safe at low doses; not metabolized | Can form aromatic decomposition products on heating | Stable; synthetic sweetener derived from toluene |
| Sucralose | 56038-13-2 | Trace–0.5% | Non-caloric; mostly excreted; heat-stable up to moderate temperatures | Decomposes to chlorinated aldehydes, dioxins, tetrachlorodibenzofurans | Resistant to metabolism; ecotoxic accumulation potential, oxidative stress, interaction with DNA, synergetic influence on the toxicity of other e-cigarette components |
| Neotame | 165450-17-9 | Trace–0.1% | Non-caloric sweetener; safe in small quantities; similar to aspartame but more stable | Can form diketopiperazine and related breakdown products on heating | Heat-stable compared to aspartame; very high sweetness potency but yields toxic metabolites when inhaled. Metabolizes to methanol |
References
- Virgili, F.; Nenna, R.; Ben David, S.; Mancino, E.; Di Mattia, G.; Matera, L.; Petrarca, L.; Midulla, F. E-Cigarettes and Youth: An Unresolved Public Health Concern. Ital. J. Pediatr. 2022, 48, 97. [Google Scholar] [CrossRef] [PubMed]
- Fearon, I.M. Human Abuse Liability Assessment of E-Cigarettes: Why, What and How? Drug Test. Anal. 2023, 15, 1211–1221. [Google Scholar] [CrossRef]
- Gades, B.A.; Alcheva, A.; Riegelsman, A.L.; Hatsukami, D.K. The Role of Nicotine and Flavor in the Abuse Potential and Appeal of Electronic Cigarettes for Adult Current and Former Cigarette and Electronic Cigarette Users: A Systematic Review. Nicot. Tab. Res. 2022, 24, 1332–1343. [Google Scholar] [CrossRef] [PubMed]
- Falarowski, C.; Pieper, E.; Rabenstein, A.; Mallock-Ohnesorg, N.; Burgmann, N.; Franzen, K.; Gertzen, M.; Koller, G.; Nowak, D.; Rahofer, A.; et al. Disposable E-Cigarettes and Their Nicotine Delivery, Usage Pattern and Subjective Effect in Occasionally Smoking Adults. Sci. Rep. 2025, 15, 16270. [Google Scholar] [CrossRef]
- Piper, M.E.; Kaye, J.T.; Piasecki, T.M.; Yang, J.J.; Buu, A. Cannabis Use Among Adults Who Smoke Tobacco: Relation With Switching From Combusted Cigarettes to E-Cigarettes or Very Low Nicotine Cigarettes. Drug Alc. Depend. 2025, 275, 112821. [Google Scholar] [CrossRef]
- Hanafin, J.; Sunday, S.; Clancy, L. Hashtags, Images and Promotions: E-Cigarette Messaging on Social Media Associated with Teenager Smoking and E-Cigarette Use in Ireland. Tob. Induc. Dis. 2025, 23, A63. [Google Scholar]
- Adawiah, R.; Maurida, N.; Ali Basri, A. The Relationship of Stress Level with Smoking Dependence in Teenagers. J. Nurs. Period. 2025, 2, 67–77. [Google Scholar]
- Rodríguez-Planas, N.; Sanz-de-Galdeano, A. Intergenerational Transmission of Gender Social Norms and Teenager Smoking. Soc. Sci. Med. 2019, 222, 122–132. [Google Scholar] [CrossRef]
- Khan, A.M.; Ahmed, S.; Farahmand, P.; Sarfraz, Z.; Farahmand, P. Vaping and Mental Health Conditions in Children: An Umbrella Review. Subst. Use Res. Treat. 2023, 17, 1–11. [Google Scholar] [CrossRef]
- Chadi, N.; Vyver, E.; Belanger, R.E. Protecting Children and Adolescents Against the Risks of Vapins. Pediatr. Child Health 2021, 26, 358–365. [Google Scholar] [CrossRef]
- Gilley, G.; Beno, S. Vaping Implications for Children and Youth. Curr. Opin. Pediatr. 2020, 32, 343–348. [Google Scholar] [CrossRef] [PubMed]
- White, D.; Bush, A.; Smyth, A.R. Why and How Should Children be Protected from the Deluge of Vaping Related Media and Marketing Overexposure. Breathe 2023, 19, 230141. [Google Scholar] [CrossRef] [PubMed]
- DeVito, E.; Jensen, K.; O’Malley, S.S.; Gueorguieva, R.; Krishnan-Sarin, S.; Valentine, G.; Jatlow, P.; Sofuoglu, M. Modulation of “Protective” Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-Cigarettes. Nic. Tob. Res. 2020, 22, 771–781. [Google Scholar] [CrossRef] [PubMed]
- Goldenson, N.I.; Leventhal, A.M.; Simpson, K.A.; Barrington-Trimis, J. A Review of the Use and Appeal of Flavored Electronic Cigarettes. Curr. Addict. Rep. 2019, 6, 98–113. [Google Scholar] [CrossRef]
- Panariello, B.; Panariello, F.D.; Misir, A.; Porto Barboza, E. An Umbrella Review of E-Cigarettes Impact on Oral Microbiota and Biofilm Buildup. Pathogens 2025, 14, 578. [Google Scholar] [CrossRef]
- Drazen, J.M.; Morrissey, S.; Campion, E.W. The Dangerous Flavors of E-Cigarettes. N. Engl. J. Med. 2019, 380, 679–680. [Google Scholar] [CrossRef]
- Ween, M.P.; Moshensky, A.; Thredgold, L.; Bastian, N.M.; Hamon, R.; Badiei, A.; Nguyen, P.T.; Herewane, K.; Jershmann, H.; Bojanowski, C.M.; et al. E-Cigarettes and Health Risks: More to the Flavor than Just the Name. Lung Cell Mol. Physiol. 2021, 320, 600–614. [Google Scholar] [CrossRef]
- Voiculescu, D.I.; Ostafe, C.; Isvoran, A. Computational Assessment of the Pharmacokinetics and Toxicity of the Intensive Sweeteners. Pharmacia 2021, 69, 1032–1041. [Google Scholar] [CrossRef]
- Amjad, M.A.; Trujillo, D.O.; Estrada-Y-Martin, R.M.; Cherian, S.V. E-Cigarette or Vaping Product Use-Associated Lung Injury: A Comprehensive Review. Int. J. Environ. Res. Public Health 2025, 22, 792. [Google Scholar] [CrossRef]
- Gaiha, S.M.; Lin, C.; Lempert, L.K. Use Patterns, Flavors, Brands and Ingredients of Nonnicotine e-Cigarettes Among Adolescents, Young Adults and Adults in the United States. JAMA 2022, 5, e2216194. [Google Scholar] [CrossRef]
- Samoilov, A.V.; Suraeva, N.M.; Zaitseva, M.V.; Kurbanova, M.N.; Stolbova, V.V. Comparative Assessment of Artificial Sweeteners via Express Biotest. Health Risk Anal. 2019, 2, 83–90. [Google Scholar] [CrossRef]
- Talhout, R.; Leventhal, A.M. Coolants, Organic Acids, Flavourings and Other Additives that Facilitate Inhalation of Tobacco and Nicotine Products: Implications for Regulation. Tob. Control 2024, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Page, M.K.; Merzianu, A.D.; Leigh, N.J.; Goniewicz, M.K. Stability of Flavoring Chemicals in e-Cigarette Liquids: A Naturalistic Product Aging Stury over 24 Months. ACS Omega 2025, 10, 15706–15715. [Google Scholar] [CrossRef] [PubMed]
- Debras, C.; Chazelas, E.; Sellem, L.; Porcher, R.; Druesne-Pecollo, N.; Esseddik, Y.; de Edelenyi, F.S.; Agaësse, C.; De Sa, A.; Lutchia, R.; et al. Artificial Sweeteners and Risk of Cardiovascular Diseases: Result from the Prospective NutriNet-Sante Cohort. BMJ 2022, 378, e71204. [Google Scholar] [CrossRef]
- Gupta, M. Sugar Substitutes: Mechanism, Availability, Current Use and Safety Concerns—An Update. Open Access Maced. J. Med. Sci. 2018, 19, 1888–1894. [Google Scholar] [CrossRef]
- Ashwell, M.; Gibson, S.; Bellisle, F.; Buttriss, J.; Drewnowski, A.; Fantino, M.; Gallagher, A.M.; de Graaf, K.; Goscinny, S.; Hardman, C.A.; et al. Expert consensus on low-calorie sweeteners: Facts, research gaps and suggested actions. Nutr. Res. Rev. 2020, 33, 145–154. [Google Scholar] [CrossRef]
- Plaza-Diaz, J.; Pastor-Villaescusa, B.; Rueda-Robles, A.; Abadia-Molina, F.; Ruiz-Ojeda, F.J. Plausible Biological Interactions of Low- and Non-Calorie Sweeteners with the Intestinal Microbiota: An Update of Recent Studies. Nutrients 2020, 12, 1153. [Google Scholar] [CrossRef]
- Mattoli, L.; Fodaroni, G.; Proietti, G.; Flamini, E.; Paoli, B.; Massa, L.; Ferrara, G.C.; Giovagnoni, E.; Gianni, M. Biodegradability of dietary supplements: Advanced analytical methods to study the environmental fate of artificial sweeteners and dyes. J. Pharm. Biomed. Anal. 2024, 255, 116575. [Google Scholar] [CrossRef]
- Méndez-García, L.A.; Bueno-Hernández, N.; Cid-Soto, M.A.; De León, K.L.; Mendoza-Martínez, V.M.; Espinosa-Flores, A.J.; Carrero-Aguirre, M.; Esquivel-Velázquez, M.; León-Hernández, M.; Viurcos-Sanabria, R.; et al. Ten-Week Sucralose Consumption Induces Gut Dysbiosis and Altered Glucose and Insulin Levels in Healthy Young Adults. Microorganisms 2022, 10, 434. [Google Scholar] [CrossRef]
- Tkach, V.V.; Morozova, T.V.; O’Neill de Mascarenhas Gaivão, I.; Ivanushko, Y.G.; Martins, J.I.F.P.; Barros, A.N. Advancement and Challenges in Sucralose Determination: A Comparative Review of Chromatographic, Electrochemical and Spectrophotometric Methods. Foods 2025, 14, 1267. [Google Scholar] [CrossRef]
- Stampe, S.; Leth-Møller, M.; Greibe, E.; Hoffmann-Lücke, E.; Pedersen, M.; Ovesen, P. Artificial Sweeteners in Breast Milk: A Clinical Investigation with a Kinetic Perspective. Nutrients 2022, 14, 2635. [Google Scholar] [CrossRef] [PubMed]
- Aguayo-Guerrero, J.A.; Méndez-García, L.A.; Manjarrez-Reyna, A.N.; Esquivel-Velázquez, M.; León-Cabrera, S.; Meléndez, G.; Zambrano, E.; Ramos-Martínez, E.; Fragoso, J.M.; Briones-Garduño, J.C.; et al. Newborns from Mothers Who Intensely Consumed Sucralose during Pregnancy Are Heavier and Exhibit Markers of Metabolic Alteration and Low-Grade Systemic Inflammation: A Cross-Sectional, Prospective Study. Biomedicines 2023, 11, 650. [Google Scholar] [CrossRef] [PubMed]
- Langevin, B.; Gopalakrishnan, M.; Kuttamperoor, J.; van den Anker, J.; Murphy, J.; Arcaro, K.F.; Daines, D.; Sylvetsky, A.C. The MILK Study: Investigating Intergenerational Transmission of Low-Calorie Sweeteners in Breast Milk. Cont. Clin. Trials Commun. 2023, 36, 101212. [Google Scholar] [CrossRef]
- Aguayo-Guerrero, J.A.; Méndez-García, L.A.; Solleiro-Villavicencio, H.; Viurcos-Sanabria, R.; Escobedo, G. Sucralose: From Sweet Success to Metabolic Controversies—Unraveling the Global Health Implications of a Pervasive Non-Caloric Artificial Sweetener. Life 2024, 14, 323. [Google Scholar] [CrossRef]
- Tkach, V.V.; Morozova, T.V.; Gaivão, I.O.d.M.; de Miranda, N.G.; Ivanushko, Y.G.; Martins, J.I.F.d.P.; Barros, A.N. Sucralose: A Review of Environmental, Oxidative and Genomic Strress. Nutrients 2025, 17, 2199. [Google Scholar] [CrossRef] [PubMed]
- Goveas, L.C. Artificial Sweeteners and the One Health Crisis: Toxicity Effects and Ecological Consequences. Discov. Appl. Sci. 2025, 7, 535. [Google Scholar] [CrossRef]
- Pasqualli, T.; Chaves, P.E.E.; Pereira, L.V.; Serpa, E.A.; Souza de Oliveira, L.F.; Mansur Machado, M. Sucralose causes non-selective CD4 and CD8 lymphotoxicity via probable regulation of the MAPK8/APTX/EID1 genes: An in vitro/in silico study. Clin. Exp. Pharmacol. Physiol. 2020, 47, 1751–1757. [Google Scholar] [CrossRef]
- Arulanandam, C.D.; Babu, V.; Soorni, V.; Prathiviraj, R. Mutagenicity and Carcinogenicity Prediction of Sugar Substitutes: An In Silico Approach with Coupound-Gene Interactions Network. Toxicol. Res. 2025, 14, 8. [Google Scholar] [CrossRef]
- El Doueihy, N.; Ghaleb, J.; Kfoury, K.; Khouzami, K.K.; Nassif, N.; Attieh, P.; Ghadieh, H.E.; Azar, S.; Kanaan, A.; Harb, F. Aspartame and Human Health: A Mini-Review of Carcinogenic and Systemic Effects. J. Xenobiot. 2025, 15, 114. [Google Scholar] [CrossRef]
- Fogel, M.N.; Khalil, A.; Khaled, S.F.; Rodriguez, E.M.; Payne, K.M.; Blount, J.R.; Petschke, M.; Nizamuddin, R.A.; Jeidel, F.; Riven, V.; et al. Aspartame and its Potential Neurocognitive Effects in Humans. Nutr. Rev. 2025, nuaf103. [Google Scholar] [CrossRef]
- dos Santos, C.A.; Pedrosa, D.S.; da Silva Santos, M. Adoçantes Sintéticos e Seus Riscos à Saúde. Rev. Ciên. Saúde 2023, 27, 122. (In Portuguese) [Google Scholar] [CrossRef]
- Chen, Y.-C.; Wang, L.Z.; Lin, Y.-F.; Lin, C.-Y.; Hsu, S.-Y.; Nacis, J.S.; Hsieh, R.-H. Aspartame Consumption Linked to Delayed Puberty and Mitochondrial Disfunction: Evidence from Human and Animal Studies. J. Nutr. Biochem. 2025, 140, 109889. [Google Scholar] [CrossRef]
- Kulhanek, A.; Baptistova, A. Chemical Composition of Electronic Cigarette E-Liquids: Overview of Current Evidence of Toxicity. Adiktologie 2020, 20, 137–144. [Google Scholar] [CrossRef]
- Castellanos, M.; Sanchez, J.M. Determination of Artificial Sweeteners: Do We Know What We Are Consuming? J. Xenobiot. 2025, 15, 164. [Google Scholar] [CrossRef] [PubMed]
- Rantasa, M.; Majer, D.; Finsgar, M. A Review of Analytical Techniques for the Determination of E-Liquid and Electronic Cigarette Aerosol Composition. J. Chromatogr. A 2025, 1748, 465859. [Google Scholar] [CrossRef]
- Robertson, N.E.; Hunsaker, H.C.; Yamamoto, M.; Cheung, K.; Poulin, B.A.; Nguyen, T.B. E-Liquid and Aerosol Characterisation of Popular Disposable E-Cigarettes. ACS Omega 2025, 10, 29615–29627. [Google Scholar] [CrossRef]
- Strongin, R.M.; Sharma, E.; Erythropel, H.; Kassem, N.; Noel, A.; Peyton, D.; Rahman, I. Chemical and Physiological Interactions Between E-Liquid Constituents: Cause for Concern. Tob. Control 2025, 34, 393–396. [Google Scholar] [CrossRef] [PubMed]
- EFSA Draft Protocol for the Exposure Assessment as Part of the Safety Assessment of Sweeteners Under the Food Additives Re-Evaluation Programme EFSA Panel on Food Additives and Flavourings. Available online: https://www.efsa.europa.eu/sites/default/files/consultation/consultation/Sweeteners_Exposure_Protocol_for_PC.pdf (accessed on 12 October 2025).
- Coccurello, R. Disrupting the Gut-Brain Axis: How Artificial Sweeteners Rewire Microbiota and Reward Pathways. Int. J. Mol. Sci. 2025, 26, 10220. [Google Scholar] [CrossRef]
- Aspartame and Other Sweeteners in Food|FDA. Available online: https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food (accessed on 12 October 2025).
- Chandra Siri, D.N.B.; Wong, Y.F. Recent Developments in Quantitative and Qualitative Analysis of E-Cigarette Liquids and Aerosols. In E-Cigarettes; Springer: Singapore, 2025; pp. 189–211. [Google Scholar] [CrossRef]
- Beverly, M.L.-S.; Chaudhary, P.P.; Dabdoub, S.M.; Kim, S.; Chatzakis, E.; Williamson, K.; Ganesan, S.M.; Yadav, M.; Ratley, G.; D’sOuza, B.N.; et al. Toxic Cultures: E-Cigarettes and the Oral Microbiome Exposome. Biofilms Microbiomes 2025, 11, 66. [Google Scholar] [CrossRef]
- Cohen, J.E.; Ibrahim, M.; Saraf, S.; Welding, K.; Luo, W.; McWhirter, K.; Clegg Smith, K.; Pankow, J.F. Velo (BAT) Buffet of Oral Nicotine Pouches in Pakistan; Varying Brand Variant Levels of Nicotine, Menthol and Other Flavour Chemicals. Tob. Control 2025, 1–7. [Google Scholar] [CrossRef]
- Lin, H.-C.; Buu, A.; Su, W.-C. Disposable E-Cigarettes and Associated Health Risks: An Experimental Study. Int. J. Environ. Res. Public Health 2022, 19, 10633. [Google Scholar] [CrossRef] [PubMed]
- Çok, I. The Use and Risks of Flavoring Agents in Electronic Cigarettes: Toxicological Approach. Addicta. Turk. J. Addict. 2023, 10, 202–209. [Google Scholar] [CrossRef]
- Ma, S.; Fang, Z. Extraction of S. grosvenorii Functional Components and Product Development: A Review. Food Mater. Res. 2004, 4, e034. [Google Scholar] [CrossRef]
- Murat, C.; Leca, G.; Ganet, P. Edulcorant pour Liquides de Cigarette Electronique. European Patent EP 3811791 A1, 28 April 2021. [Google Scholar]
- Fagan, P.; Pokhrel, P.; Herzog, T.A.; Moolchan, E.T.; Cassel, K.D.; Franke, A.A.; Li, X.; Pagano, I.; Trinidad, D.R.; Sakuma, K.-L.K.; et al. Sugar and Aldehyde Content in Flavored Electronic Cigarette Liquids. Nicot. Tob. Res. 2018, 20, 985–992. [Google Scholar] [CrossRef]
- Kubica, P.; Wasik, A.; Kot-Wasik, A.; Namiesnik, J. An Evaluation of Sucrose as a Possible Contaminant in E-Liquids for Electronic Cigarettes by Hydrophylic Interaction Liquid Chromatography—Tandem Mass Spectrometry. Anal. Bioanal. Chem. 2014, 406, 3013–3018. [Google Scholar] [CrossRef]
- Soussy, S.; El-Hellani, A.; Baalbaki, R.; Salman, R.; Shihadeh, A.; Saliba, N. Detection of 5-hydroxymethylfurfural and Furfural in the Aerosol of Electronic Cigarettes. Tob. Control 2016, 25, 88–93. [Google Scholar] [CrossRef]
- Sravan, T.; Spandana, K. Sorbitol—Its Applications in Different Fields. Agric. Food E-Newsl. 2021, 3, 2–4. [Google Scholar]
- del Pozo, S.; Gómez-Martínez, S.; Díaz, L.E.; Nova, E.; Urrialde, R.; Marcos, A. Potential Effects of Sucralose and Saccharin on Gut Microbiota: A Review. Nutrients 2022, 14, 1682. [Google Scholar] [CrossRef]
- The Synthesis of Sucralose from Sucrose. Available online: https://www.sciencesnail.com/science/the-synthesis-of-sucralose-from-sucrose (accessed on 11 September 2025).
- Schlappack, T.; Kappacher, C.; Demetz, M.; Jakschitz, T.; Bonn, G.K.; Huck, C.W.; Rainer, M. Ambient Mass-Spectrometry and Near-Infrared Spectroscopy—A Direct Comparison of Methods for the Quantification of Sucralose in E-Liquids. Anal. Methods 2023, 15, 2448–2455. [Google Scholar] [CrossRef]
- Hu, J.; Feng, J.; Bai, Y.; Yao, Z.-S.; Wu, X.-Y.; Hong, X.-Y.; Lu, G.D.; Xue, K. Sucralose Promotes Benzo(a)Pyrene-Induced Renal Toxicity in Mice by Regulating P-Glycoprotein. Antioxidants 2025, 14, 474. [Google Scholar] [CrossRef]
- Duell, A.K.; McWhirther, K.; Korzun, T.; Strongin, R.M.; Peyton, D.H. Sucralose-Enhanced Degradation of Electronic Cigarette Liquids During Vaping. Chem. Res. Toxicol. 2019, 32, 1241–1249. [Google Scholar] [CrossRef] [PubMed]
- Kerber, P.K.; Peyton, D.H. Kinetics of Aldehyde Flavorant-Acetal Formation in E-Liquids with Different E-Cigarette Solvents and Common Additives Studied by 1H NMR Spectroscopy. Chem. Res. Toxicol. 2022, 35, 1410–1417. [Google Scholar] [CrossRef] [PubMed]
- Rosbrook, K.; Erythropel, H.C.; DeWinter, T.M.; Falinski, M.; O’Malley, S.; Krishnan-Sarin, S.; Anastas, P.T.; Zimmerman, J.B.; Green, B.G. The Effect of Sucralose on Flavor Sweetness in Electronic Cigarettes Varies Between Delivery Devices. PLoS ONE 2017, 12, e0185334. [Google Scholar] [CrossRef] [PubMed]
- Yan, X.; Chen, Z.; Rong, X.; Chen, Z.; Wu, G.; Dong, Z.; Fu, Y.; Hai, T. The Impact of Sucralose and Neotame on the Safety of Metal Precipitation in Electronic Cigarettes. Front. Physiol. 2024, 15, 1437042. [Google Scholar] [CrossRef]
- Moser, D.; Leitner, P.; Filipek, P.A.; Hussain, S.; Rainer, M.; Jakschitz, T.; Rode, B.M.; Bonn, G.K. Quantification and Cytotoxicity of Degradation Products (Chloropropanols) in Sucralose Containing E-Liquids with Propylene Glycol and Glycerol as Base. Toxicol. Appl. Pharmacol. 2021, 430, 115727. [Google Scholar] [CrossRef]
- El-Hellani, A.; Soule, E.; Daoud, M.; Salman, R.; El Hage, R.; Ardati, O.; El-Kaassamani, N.; Talih, S.; Saliba, N.; Shihadeh, A. Assessing Toxicant Emissions from E-Liquids with DIY Additives Used in Response to a Potential Flavour Ban in E-Cigarettes. Tob. Control 2022, 31, 245–248. [Google Scholar] [CrossRef]
- Kim, S.A.; Smith, S.; Beauchamp, C.; Song, Y.; Chiang, M.; Giuseppetti, A.; Frukhtbeyn, S.; Shaffer, I.; Wilhide, J.; Routkevitch, D.; et al. Cariogenic Potential of Sweet Flavors in Electronic-Cigarette Liquids. PLoS ONE 2018, 13, e0203717. [Google Scholar] [CrossRef]
- Gaur, S.; Agnihotri, R. The Role of Electronic Cigarettes in Dental Caries: A Scoping Review. Scientifica 2023, 2023, 9980011. [Google Scholar] [CrossRef]
- Maloney, S.F.; Hoetger, C.; Bono, R.S.; Lester Scholtes, R.; Combs, M.; Karaoghlanian, N.; Lipato, T.; Breland, A.; Eissenberg, T. Assessment of Human Abuse Potential of an Unflavored, Sucralose-Sweetened Electronic Cigarette in Combustible Cigarette Smokers. Exp. Clin. Psychopharmacol. 2024, 32, 588–603. [Google Scholar] [CrossRef]
- Kerber, P.J.; Duell, A.; Powers, M.; Strongin, R.; Peyton, D. Effects of Common e-Liquid Flavorants and Added Nicotine on Toxicant Formation during Vaping Analyzed by 1H NMR Spectroscopy. Chem. Res. Toxicol. 2022, 35, 1267–1276. [Google Scholar] [CrossRef]
- Stepanov, I.; Berman, M.; Brinkman, M.C.; Carll, A.; Exil, V.; Hansen, E.G.; El Hellani, A.; Jabba, S.V.; Kassem, N.O.F.; Rezk-Hanna, M.; et al. Sugars in Tobacco Products: Toxicity Research and Implications for Tobacco Product Regulation. Chem. Res. Toxicol. 2025, 38, 747–758. [Google Scholar] [CrossRef] [PubMed]
- Rodgmann, A. Some Studies of the Effects of Additives on Cigarette Mainstream Smoke Properties. II. Casing Materials and Humectants. Beitr. Tabakforsch. 2002, 20, 279–299. [Google Scholar] [CrossRef]
- Miao, S.; Beach, E.S.; Sommer, T.J.; Zimmermann, J.B.; Jordt, S.E. High-Intensity Sweeteners in Alternative Tobacco Products. Nicot. Tob. Res. 2016, 18, 2169–2173. [Google Scholar] [CrossRef]
- Rizk, R.M.; Soliman, M.I.; Rashed, A.A. Potential Mutagenicity of Some Artificial Sweeteners Using Allium Test. Asian J. Adv. Basic Sci. 2016, 4, 27–40. [Google Scholar]
- Erythropel, H.C.; Jabba, S.V.; Silinski, P. Variability of Constituents of E-Cigarette Products Containing Nicotine Analogues. JAMA 2024, 332, 753–755. [Google Scholar] [CrossRef] [PubMed]
- Erythropel, H.C.; Jabba, S.V.; Mellinghof, R.A. Prevalence of Artificial Sweetener Neotame in US/Marketed Disposable E/Cigarettes. JAMA 2025, 334, 448–449. [Google Scholar] [CrossRef]
- Salam, S.; Saliba, N.A.; Shihadeh, A.; Eissenberg, T.; El-Hellani, A. Flavor-Toxicant Correlation in E-Cigarettes: A Meta-Analysis. Chem. Res. Toxicol. 2020, 33, 2932–2938. [Google Scholar] [CrossRef]
- Rantasa, M.; Majer, D.; Finsgar, M. The Analysis of E-Liquids: A Study on Chemical Diversity and Metal Content Using Gas Chromatography-Mass Spectrometry and Inductively Coupled Plasma-Mass Spectrometry. J. Separ. Sci. 2024, 47, 2400443. [Google Scholar] [CrossRef]
- Heywood, J.; Abele, G.; Langenbach, B.; Litvin, S.; Smallets, S.; Paustenbach, D. Composition of e-Cigarette Aerosols: A Review and Risk Assessment of Selected Compounds. J. Appl. Toxicol. 2024, 45, 364–386. [Google Scholar] [CrossRef]
- Pennington, C.; Hernandez Aldave, S. Disposable Electronic Cigarettes: Chemical Composition in New and Used Devices. J. Chromatogr. A 2025, 1758, 466178. [Google Scholar] [CrossRef]
- Farber, H.J. What Do We Know about the Harms of Electronic Cigarettes? Pediatr. Allergy Immunol. Pulmonol. 2025, 38, 1. [Google Scholar] [CrossRef]
- McAlinden, K.D.; Lu, W.; Eapen, M.S.; Sohal, S.S. Electronic Cigarettes: Modern Instruments for Toxic Lung Delivery and Posing Risk for the Developing of Chronic Disease. Int. J. Biochem. Cell Biol. 2021, 106, 106039. [Google Scholar] [CrossRef]
- Jabba, S.V.; Silinski, P.; Yang, A.Y.; Ouyang, W.; Jordt, S. Artificial Sweeteners in US-Marketed Oral Nicotine Pouch Products: Correlation With Nicotine Contents and Effects on Product Preference. Nicot. Tob. Res. 2024, ntae290. [Google Scholar] [CrossRef]
- Vanhee, C.; Dill, D.; Canfyn, M.; Tuenter, E.; Barhdadi, S. The Emergence of a Novel Synthetic Nicotine Analog 6/Methyl Nicotine (6-MN) in Proclaimed Tobacco- and Nicotine-Free Pouches Available in Europe. Drug Test. Anal. 2024, 17, 1368–1379. [Google Scholar] [CrossRef]
- Felicione, N.J.; Ozga, J.E.; Eversole, A.; Hart, J.L.; Tackett, A.; Hrywna, M.; Halquist, M.; Stanton, C.S. Oral Nicotine Pouches: Rising Popularity and State of Science. Public Health Rep. 2025, 2025, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Schichlein, K.D.; Kim, H.-Y.H.; Love, C.A.; Lee, T.N.G.; Esther, C.R.; Porter, N.A.; Rebuli, M.E.; Ehrmann, B.M.; Clapp, P.W.; Jaspers, I. Melatonin Wapes Contain Potential Contaminants and Alter the Human Bronchial Epitelial Transcriptome. Chem. Res. Toxicol. 2024, 37, 1919–1923. [Google Scholar] [CrossRef] [PubMed]
- Moldoveanu, S.; Bussey, R.O. General Information on Tobacco and Nicotine Products. In Analytical Methods for Tobacco and Nicotine Harm Reduction; Springer: Cham, Switzerland, 2025. [Google Scholar] [CrossRef]
- Aldeek, F.; Wagner, K.; Haase, V.; Sublette, E.; Lopez, V. Analysis and Toxicological Evaluation of Nicotine Degradants and Impurities in Oral Tobacco Products: A Case Study of on! PLUS Nicotin Pouches. ACS Omega 2025, 10, 6267–6278. [Google Scholar] [CrossRef] [PubMed]
- Mansour, A.A.; Mortada, W.I.; Awad, F.S.; Molouk, A.F.S.; Khalifa, M.E.; Abdallah, A.B. Carbon-Dot-Based Imprinted Electrochemical Sensor for Ultrasensitive Detection of Sucralose in Real Samples. Mater. Chem. Front. 2025, 20, 3075–3085. [Google Scholar] [CrossRef]
- Tian, Y.; Wang, H.; Chen, H.; Li, X.; Lu, F.; Ma, S.; Wang, W.; Wu, J.; Tang, J.; Feng, P.; et al. Toxicity Evaluation in Rats Following 28 Days of Inhalation Exposure to Xylitol Aerosol. Toxicol. Res. 2021, 10, 1177–1186. [Google Scholar] [CrossRef]
- Kassem, O.F.N.; Strongin, R.M.; Stroup, A.; Brinkman, M.C.; El-Hellani, A.; Erythropel, H.C.; Etemadi, A.; Goniewicz, M.L.; Hansen, E.C.; Kassem, N.O.; et al. Toxicity of Waterpipe Tobacco Smoking: The Role of Flavors, Sweeteners, Humectants and Charcoal. Toxicol. Sci. 2024, 201, 159–173. [Google Scholar] [CrossRef]
- Afolabi, S.O.; Olaoye, S.O.; Nyamgee, A.; Njan, A.A. Comparative Effects of Alternate Tobacco Products and Traditional Tobacco Smoking on Various Organ/Systems: A Guide to Regulators and Health Policy Markers. Toxicol. Rep. 2025, 15, 102100. [Google Scholar] [CrossRef] [PubMed]
- Ghuman, A.; Choudhary, P.; Kasana, J.; Kumar, S.; Sawhney, H.; Bhat, R.; Kashwani, R. A Systematic Literature Review on the Composition, Health impacts and Regulatory Dynamics of Vaping. Cureus 2024, 16, e66068. [Google Scholar] [CrossRef] [PubMed]
- Hahn, J.; Monakhova, Y.B.; Hengen, J.; Kohl-Himmelseher, M.; Schüssler, J.; Hahn, H.; Kuballa, T.; Lachenmeier, D.W. Electronic Cigarettes: Overview of Chemical Composition and Exposure Estimation. Tob. Induc. Dis. 2014, 12, 23. [Google Scholar] [CrossRef] [PubMed]
- Sobczak, A.; Kosmider, L. Advantages and Disadvantages of Electronic Cigarettes. Toxics 2023, 11, 66. [Google Scholar] [CrossRef]
- Travis, N.; Knoll, M.; Cook, S.; Oh, H.; Cadham, C.J.; Sánchez-Romero, L.M.; Levy, D.T. Chemical Profiles and Toxicity of Electronic Cigarettes: An Umbrella Review and Methodological Considerations. Int. J. Environ. Res. Public Health 2023, 20, 1908. [Google Scholar] [CrossRef]
- de Medeiros, K.S.; Pacheco, B.F.P.; de Oliveira, P.E.; de Góis Nogueira, I.L.; Diógenes, V.R.B.; Fernandes, F.G.; Fernandes, G.C.; de Moura Santos, E.; Rêgo, A.C.M.D.; Araújo-Filho, I. Impact of e-Cigarettes as Cancer Risk: A Protocol for Systematic Rebiew and Meta-Analysis. Medicine 2023, 102, e32233. [Google Scholar] [CrossRef]
- Pinto, M.I.; Thissen, J.; Hermes, N.; Cunningham, A.; Digard, H.; Murphy, J. Chemical Characterization of the Vapor Emitted by an e-Cigarette Using a Ceramic Wick-Based Technology. Sci. Rep. 2022, 12, 16497. [Google Scholar] [CrossRef]
- Carll, A.P.; Arab, C.; Salatini, R.; Miles, M.D.; Nystoriak, M.A.; Fulghum, K.L.; Riggs, D.W.; Shirk, G.A.; Theis, W.S.; Talebi, N.; et al. E-Cigarettes and Their Lone Constituents Induce Cardiac Arrhythmia and Conduction Defects in Mice. Nature Commun. 2022, 13, 6088. [Google Scholar] [CrossRef]
- Cunningham, A.; McAdam, K.; Thissen, J.; Digard, H. The Evolving E-Cigarette Comparative Chemical Analyzes of E-Cigarette Vapor and Cigarette Smoke. Front. Toxicol. 2020, 2, 586674. [Google Scholar] [CrossRef]
- Valenzuela Toledo, E.F.; Simões, I.F.; Tavares de Farias, M.; Cavalcante Minho, L.C.; de Lima Conceição, J.; Lopes dos Santos, W.N.; Ribeiro de Mesquita, P.R.; Freitas Santos Junior, A. A Comprehensive Review of the Harmful Components in Electronic Cigarettes. Toxics 2025, 13, 268. [Google Scholar] [CrossRef]
- Kopa-Stojak, P.N.; Pawliczak, R. Disposable Electronic Cigarettes—Chemical Composition and Health Effects of Their Use. A Systematic Review. Toxicol. Mech. Methods 2025, 35, 250–261. [Google Scholar] [CrossRef]
- Effah, F.; Bi Shaikh, S.; Chalupa, D.; Faizan, M.I.; Elder, A.; Rahman, I. High-Resistance Coils in E-Cigarettes Increase Heavy Metals Leaching into Aerosols to Cause Oxidants Generation in Human Bronchial Epithelial Cells at Air-Liquid Interface: A Unique Non-Aninal Methodological Approach on Vaping Studies. NAM J. 2025, 1, 100060. [Google Scholar] [CrossRef]
- Effah, F.; Sun, Y.; Friedman, A.; Rahman, I. Emerging Nicotine Analog 6-Methylnicotine Increases Reactive Oxygen Species in Aerosols and Cytotoxicity in Human Bronchial Epitelial Cells. Toxicol. Lett. 2025, 405, 9–15. [Google Scholar] [CrossRef] [PubMed]
- Barhdadi, S.; Mertens, B.; Van Bossuyt, M.; van de Maele, J.; Anthonissen, R.; Canfyn, M.; Courselle, P.; Rogiers, V.; Deconinck, E.; Vanhaecke, T. Identification of Flavouring Substances of Genotoxic Concern, Present in E-Cigarette Refills. Food Chem. Toxicol. 2021, 137, 111864. [Google Scholar] [CrossRef] [PubMed]
- Taylor, E.; Simonavicius, E.; McNeill, A.; Brose, L.S.; East, K.; Marczylo, T.; Robson, D. Exposure to Tobacco-Specific Nitrosamines Among People who Vape, Smoke or Do Neither: A Systematic Review and Meta-Analysis. Nicot. Tob. Res. 2024, 26, 257–269. [Google Scholar] [CrossRef] [PubMed]
- Farsalinos, K.; Gillman, G.; Poulas, K.; Voudris, V. Tobacco-Specific Nitrosamines in Electronic Cigarettes: Comparison between Liquid and Aerosol Levels. Int. J. Environ. Res. Public Health 2015, 12, 9046–9053. [Google Scholar] [CrossRef]




| Natural Sweetener | Nature of Substance | Objections | Nature of the Study | CAS Number: | Reference |
|---|---|---|---|---|---|
| Erythritol, xylitol | Carbohydrate-derived polyol | Cytotoxicity, Partial dehydratation, Metabolism, dependent on gut microbiota | In vivo, in vitro | 149-32-6, 87-99-0 | [51] |
| Xylitol (in the presence of synthetic sucralose) | Carbohydrate-derived polyol (involving carbohydrate-derived chlorohydrin) | Sweetener concentration, non-correspondent to the declared, possible metabolic synergetic effect between natural and artificial sweetener, sucralose, and xylitol dehydratation and its products | In vitro | 87-99-0, 56038-13-2 | [52] |
| Perillartine, ethylmaltol | Oxyme of an unsaturated aldehyde, in the presence of an ether | Sweetener, used mostly in Japan. Possible substitution of sucralose and other artificial sweeteners. Hydroxylamine formed during metabolism in some people. Dehydratation of ethylmaltol | In vitro | 30950-27-7, 4940-11-8 | [53] |
| Maltol, ethylmaltol, ethylacetate | Carbohydrate-derived polyol and its ether in the presence of a common ester | Decomposition, yielding toxic aldehydes | In vivo | 4940-11-8, 118-71-8, 141-78-6 | [54] |
| Mogroside V | A trisaccharide derivative of a terpenoid compound | Thermal stability. Possible substitute of sucralose. Objections about metabolism of inhaled form | In vitro | 88901-36-4 | [55] |
| Neohesperidine dihydrochalcone (in the presence of neotame) | Polyphenolic compound (an aromatic amino acid derivative being involved) | Synergetic toxic effect of inhaled form. Concurrence between the antioxidant action of neohesperidine and the oxidative stress of neotame | In vitro | 13241-33-3, 165450-17-9 | [56] |
| Glucose | Carbohydrate | Glucose intake and insulin secretion, affected by Nicotiana alkaloids. Dehydratation products involved | In vivo | 50-99-7 | [57] |
| Sugar | Carbohydrate | Glucose intake and insulin secretion, affected by Nicotiana alkaloids. Dehydratation products involved | In vivo | 57-50-1 | [58] |
| Fructose | Carbohydrate | Dehydratation products include furfural derivatives and aldehydes, which may be toxic when inhaled | In vivo | 57-48-7 | [59] |
| Sorbitol | Carbohydrate-derived polyol | Dehydratation leading to toxic compounds in aerosol | In vivo | 50-70-4 | [60] |
| Vaping Products | Biological Activity | Experiment Type | Reference |
|---|---|---|---|
| E-liquid (in the presence of neotame) | Sweetener concentration, non-correspondent to the declared, possible metabolic synergetic effect between natural and artificial sweetener, sucralose and xylitol dehydratation and its products, ↑ toxic carbonyl compounds | In vitro | [52] |
| E-liquid aerosol | ↑ toxic chloroorganic degradation products | In vitro, in vivo | [63] |
| Benzo[a]pyrene exposure | ↑ renal toxicity, PGP inhibition, ↑ ROS | In vivo | [64] |
| E-liquid and e-liquid aerosol | ↑ sucralose degradation rate, ↑ solvents oxidation and dehydratation rate, ↑ toxic chloroorganic degradation products, ↑ toxic carbonyl compounds | In vitro | [65] |
| E-liquid | ↑ sucralose degradation rate, ↑ solvents oxidation and dehydratation rate, ↑ toxic chloroorganic degradation products, ↑ toxic carbonyl compounds | In vivo | [66] |
| E-liquid and e-liquid aerosol | ↑ flavor perception in cartridge aerosol | In vivo | [67] |
| E-liquid and e-liquid aerosol | ↑ heavy metal precipitation, ↑ metallic parts corrosion, ↑ cytotoxic effect ↓ cells viability, neotame suggested as a safer alternative to sucralose | In vitro | [68] |
| E-liquid and e-liquid aerosol | ↑ toxic chloroorganic degradation products, ↑ toxic carbonyl compounds, ↓ cells’ metabolic activity, sucralose ban in e-liquids suggested | In vitro | [69] |
| E-liquid and e-liquid aerosol | ↑ ROS by different manner, depending on nicotine formulation | In vivo | [70] |
| E-liquid aerosol | ↑ enamel contact, ↑ cariogenesis, ↓tooth hardness | In vivo | [71] |
| E-liquid | ↑ enamel contact, ↑ cariogenesis, ↓tooth hardness | In vivo | [72] |
| E-liquid and e-liquid aerosol | ↑ HAP | In vivo | [73] |
| E-liquid | ↑ sucralose degradation rate, ↑ solvents oxidation and dehydratation rate, ↑ toxic chloroorganic degradation products, ↑ toxic carbonyl compounds | In vitro | [74] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tkach, V.V.; Morozova, T.V.; Gaivão, I.; Martins-Bessa, A.; Ivanushko, Y.G.; Martins, J.I.F.d.P.; Barros, A.N. Sweeteners in E-Cigarettes: A Minireview of Flavoring and Biological Action. J. Xenobiot. 2025, 15, 209. https://doi.org/10.3390/jox15060209
Tkach VV, Morozova TV, Gaivão I, Martins-Bessa A, Ivanushko YG, Martins JIFdP, Barros AN. Sweeteners in E-Cigarettes: A Minireview of Flavoring and Biological Action. Journal of Xenobiotics. 2025; 15(6):209. https://doi.org/10.3390/jox15060209
Chicago/Turabian StyleTkach, Volodymyr V., Tetiana V. Morozova, Isabel Gaivão, Ana Martins-Bessa, Yana G. Ivanushko, José Inácio Ferrão de Paiva Martins, and Ana Novo Barros. 2025. "Sweeteners in E-Cigarettes: A Minireview of Flavoring and Biological Action" Journal of Xenobiotics 15, no. 6: 209. https://doi.org/10.3390/jox15060209
APA StyleTkach, V. V., Morozova, T. V., Gaivão, I., Martins-Bessa, A., Ivanushko, Y. G., Martins, J. I. F. d. P., & Barros, A. N. (2025). Sweeteners in E-Cigarettes: A Minireview of Flavoring and Biological Action. Journal of Xenobiotics, 15(6), 209. https://doi.org/10.3390/jox15060209

